Empirical Study on the Transparency of Security Risk Information in Chinese Listed Pharmaceutical Enterprises Based on the ANP-DS Method

Table 6

Judgment matrix of the Bi of transparency for listed pharmaceutical enterprises in security risk Information.

B	B1	B2	B3	B4	B5	B6	B7	B8	B9	Local weight
B1	1	3	2	1						0.351
B2	1/3	1	2	3						0.110
B3	1/2	1/2	1	2						0.189
B4	1	1/3	1/2	1						0.351
B5					1	1	2	2	2	0.277
B6					1	1	2	3	3	0.328
B7					1/2	1/2	1	1	1	0.139
B8					1/2	1/3	1	1	1	0.128
B9					1/2	1/3	1	1	1	0.128